Congenital hypomyelinating neuropathy attributable to a de novo p.Asp61Asn mutation of the myelin protein zero gene

Pediatr Neurol. 2013 Jan;48(1):59-62. doi: 10.1016/j.pediatrneurol.2012.09.011.

Abstract

We describe a boy aged 2 years and 11 months with congenital hypomyelinating neuropathy attributable to a de novo heterozygous missense mutation of c.181 G>A (p.Asp61Asn) in the myelin protein zero gene. A nerve conduction study indicated markedly reduced motor conduction velocities in the upper and lower extremities. Stimuli of up to 50-100 mA were necessary for nerve activation, suggesting diseased nerves with greatly decreased excitability. A sural nerve biopsy revealed a marked loss of large myelinated fibers, the absence of myelin breakdown products, occasional basal lamina onion-bulb formations, and tomacula-like structures. The p.Asp61Asn mutation is novel in congenital hypomyelinating neuropathy, but was previously reported in a patient with Charcot-Marie-Tooth disease type 1.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asparagine / genetics*
  • Aspartic Acid / genetics*
  • Charcot-Marie-Tooth Disease / genetics*
  • Charcot-Marie-Tooth Disease / pathology
  • Child, Preschool
  • Humans
  • Male
  • Myelin P0 Protein / genetics*
  • Sural Nerve / pathology
  • Sural Nerve / ultrastructure

Substances

  • MPZ protein, human
  • Myelin P0 Protein
  • Aspartic Acid
  • Asparagine

Supplementary concepts

  • Charcot-Marie-Tooth disease, Type 4E